Arak, Hacı, and Tülay Kuş. 2024. “Prognostic and Predictive Significance of HER2-Low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy”. European Journal of Therapeutics, May. https://doi.org/10.58600/eurjther2151.